Summary
The molecular analysis of 127 DMD/BMD patients showed that 73 of them (57%) had deletions in the dystrophin gene. Two different methods were used in this study: (a) hybridization of HindIII-digested genomic DNA with nine cDNA probes corresponding to the entire 14 kb cDNA of the DMD gene; and (b) simultaneous amplification of nine exons of the DMD gene (multiplex DNA amplification) by the polymerase chain reaction (PCR). When the deletion breakpoints of the intragenic deletions were analyzed with regard to their phenotypic consequences, nine patients were found to represent exceptions to the reading-frame hypothesis. Information regarding mental development was also available for 61 of the 73 deleted patients and for 34 of the 54 non-deleted ones. The proportion of mentally retarded patients was found to be similar in the two groups (deleted, 15%; non-deleted, 18%). Finally, in one family, a junction fragment present in the patient was not found in the peripheral blood DNA of the mother but was present in the sister, thus indicating germline mosaicism in the mother.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bakker E, Van Broeckhoven C, Bonten EJ, Van de Vooren MJ, Veenema H, Van Hul W, Van Ommen GJB, Vandenberghe A, Pearson PL (1987) Germline mosaicism and Duchenne muscular dystrophy mutations. Nature 329:554–558
Bakker E, Veenema H, Den Dunnen JT, Van Broeckhoven C, Grootscholten PM, Bonten EJ, Van Ommen GJB, Pearson PL (1989) Germinal mosaicism increases the recurrence risk for ‘new’ Duchenne muscular dystrophy mutations. J Med Genet 26:553–559
Baumbach LL, Chamberlain JS, Ward PA, Farwell NJ, Caskey CT (1989) Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies. Neurology 39:465–474
Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley R, Miller JP, Province MA, and the CIDD Group (1983) Clinical investigations in Duchenne muscular dystrophy. II. Determination of the “power” of therapeutic trials based on the natural history. Muscle Nerve 6:91–103
Chamberlain JS, Caskey CT (1990) Duchenne muscular dystrophy. Curr Neurol 10:65–103
Chamberlain JS, Gibbs RA, Ranier JE, Nguyen PN, Caskey CT (1988) Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res 16:11141–11156
Chamberlain JS, Gibbs RA, Ranier JE, Caskey CT (1989) Multiplex PCR for diagnosis of Duchenne muscular dystrophy. In: Innis M, Gelfand D, Sninski J, White T (eds) PCR: protocols and applications — a laboratory manual. Academic Press, New York, pp 272–281
Church GM, Gilbert W (1984) Genomic sequencing. Proc Natl Acad Sci USA 81:1991–1995
Cole CG, Coyne A, Hart KA, Sheridan R, Walker A, Johnson L, Hodgson S, Bobrow M (1988) Prenatal testing for Duchenne and Becker muscular dystrophy. Lancet I:262–265
Darras BT, Francke U (1987) A partial deletion of the muscular dystrophy gene transmitted twice by an unaffected male. Nature 329:556–558
Darras BT, Koenig M, Kunkel LM, Francke U (1988a) Direct method for prenatal diagnosis and carrier detection in Duchenne/Becker muscular dystrophy using the entire dystrophin cDNA. Am J Med Genet 29:713–726
Darras BT, Blattner P, Harper JF, Spiro AJ, Alter S, Francke U (1988b) Intragenic deletions in 21 Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD) families studied with the dystrophin cDNA: location of breakpoints on HindIII and BglII exon-containing fragment maps, meiotic and mitotic origin of the mutations. Am J Hum Genet 43:620–629
Den Dunnen JT, Grootscholten PM, Bakker E, Blonden LAJ, Ginjaar HB, Wapenaar MC, Van Paassen HMB, Van Broeckhoven C, Pearson PL, Van Ommen GJB (1989) Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet 45:835–847
Emery AEH (1987) Duchenne muscular dystrophy. (Oxford Monographs on Medical Genetics, no 15). Oxford University Press, Oxford, pp 71–91
Feener CA, Koenig M, Kunkel LM (1989) Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus. Nature 338:509–511
Feinberg AP, Vogelstein B (1983) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6–13
Feinberg AP, Vogelstein B (1984) A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Addendum. Anal Biochem 137:267–268
Forrest SM, Cross GS, Flint T, Speer A, Robson KJH, Davies K (1988) Further studies of gene deletions that cause Duchenne and Becker muscular dystrophies. Genomics 2:109–114
Gilgenkrantz H, Chelly J, Lambert M, Recan D, Barbot JC, Van Ommen GJB, Kaplan JC (1989) Analysis of molecular deletions with cDNA probes in patients with Duchenne and Becker muscular dystrophies. Genomics 5:574–580
Gillard EF, Chamberlain JS, Murphy EG, Duff CL, Smith B, Burghes AHM, Thompson MW, Sutherland J, Oss I, Bodrug SE, Klamut HJ, Ray PN, Worton RG (1989) Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. Am J Hum Genet 45:507–520
Hall JG (1988) Review and hypotheses: somatic mosaicism: observations related to clinical genetics. Am J Hum Genet 43:355–363
Hoffman EP, Brown RH Jr, Kunkel LM (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919–928
Hoffman EP, Fishbeck KH, Brown RH, Johnson M, Medori R, Loike JD, Harris JB, Waterston R, Brooke M, Specht L, Kupsky W, Chamberlain J, Caskey CT, Shapiro F, Kunkel LM (1988) Dystrophin quality and quantity determines the clinical severity of Duchenne Becker muscular dystrophies. N Engl J Med 318:1363–1368
Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM (1987) Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50:509–517
Koenig M, Monaco AP, Kunkel LM (1988) The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53:219–228
Koenig M, Beggs AH, Moyer M, Scherpf S, Heindrich K, Bettcken T, Meng G, Muller CR, Lindlöf M, Kääriäinen H, Chapelle A de la, Kiuru A, Savontaus M-L, Gilgenkrantz H, Recan D, Chelly J, Kaplan J-C, Covone AE, Archidiacono N, Romeo G, Liechti-Gallati S, Schneider V, Braga S, Moser H, Darras BT, Murphy P, Francke U, Chen D, Morgan G, Denton M, Greenberg CR, Wrogemann K, Blonden LAJ, Van Paassen HMB, Van Ommen GJB, Kunkel LM (1989) The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet 45:498–506
Lemaire C, Heilig R, Mandel J-L (1988) The chicken dystrophin cDNA: striking conservation of the C-terminal coding and 3′ untranslated regions between man and chicken. EMBO J 7:4157–4162
Lindlöf M, Kiuru A, Kääriäinen H, Kalimo H, Lang H, Pihko H, Rapola J, Somer H, Somer M, Savontaus M-L, Capelle A de la (1989) Gene deletions in X-linked muscular dystrophy. Am J Hum Genet 44:496–503
Malhotra SB, Hart KA, Klamut HJ, Thomas NST, Bodrug SE, Burghes AHM, Bobrow M, Harper PS, Thompson MW, Ray PN, Worton RG (1988) Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science 242:755–759
Monaco AP, Kunkel LM (1988) Cloning of the Duchenne/Becker muscular dystrophy locus. Adv Hum Genet 17:61–98
Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM (1988) An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 2:90–95
Romeo G, Roncuzzi L, Ferlini A, Pirozzi A, Nobile C (1986) New mutations in Duchenne and Becker muscular dystrophies (abstract). Am J Hum Genet 39 [Suppl]:99
Rowland LP (1988) Clinical concepts of Duchenne muscular dystrophy. The impact of molecular genetics. Brain 111:479–495
Speer A, Spiegler AWJ, Hanke R, Grade K, Giertler U, Schieck J, Forrest S, Davies KE, Neumann R, Bollmann R, Bommer C, Sommer D, Coutelle C (1989) Possibilities and limitation of prenatal diagnosis and carrier determination for Duchenne and Becker muscular dystrophy using cDNA probes. J Med Genet 26:1–5
Walton JN, Gardner-Medwin D (1981) In: Walton J (ed) Disorders of voluntary muscle. Churchill Livingstone, Edinburgh, pp 481–524
Wapenaar MC, Kievits T, Hart KA, Abbs S, Blonden LAJ, Den Dunnen JT, Grootscholten PM, Bakker E, Verellen-Dumoulin C, Bobrow M, Van Ommen GJB, Pearson PL (1988) A deletion hot spot in the Duchenne muscular dystrophy gene. Genomics 2:101–108
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Covone, A.E., Lerone, M. & Romeo, G. Genotype-phenotype correlation and germline mosaicism in DMD/BMD patients with deletions of the dystrophin gene. Hum Genet 87, 353–360 (1991). https://doi.org/10.1007/BF00200919
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00200919